Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...

Indiana's workforce is feeling pressure to return to the office, but a good portion of employees still like hybrid work. Is ...

Eli Lilly (LLY) is set to announce Q4 earnings results, with analysts expecting positive growth driven by key drugs and new product launches.

Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

Alliance Wealth Advisors LLC UT raised its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 205.1% ...

Resonant Capital Advisors LLC boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.4% in the fourth ...

Bank of America updated their “Growth 10” stocks, which are the 10 highest ranking growth stocks according to their ...

Reebok honors one of their most iconic sneakers with a special edition release The post Reebok celebrates big with new ...

The global vulvodynia treatment market is poised for significant growth, with sales expected to rise from USD 6.7 billion in 2025 to USD 12.4 billion by 2035, reflecting a CAGR of 6.3% over the ...

Boston-area filmer Jason Jenkins put together this video on Beantown’s well-known spot you've seen over the years in numerous ...

The Danish pharmaceutical company expects demand for obesity and diabetes drugs to rise, but forecasts sales growth to slow down this year. Read more.